Agios Pharmaceuticals (AGIO) Shares Outstanding (2012 - 2026)
Agios Pharmaceuticals' (AGIO) quarterly Shares Outstanding (Entity) came in at $59.5 million in Q2 2026, up 2.69% YoY from $57.9 million in Q2 2025, and up 1.2% on a QoQ basis from $58.8 million in Q1 2026.
Agios Pharmaceuticals (AGIO) Shares Outstanding (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 15 years of Shares Outstanding (Entity) data on file, last reported at $59.5 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 2.69% year-over-year to $59.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $59.5 million (up 2.69% YoY) and the FY2025 annual result came in at $58.0 million, up 2.05% from the prior year.
- Shares Outstanding (Entity) rose to $59.5 million in Q2 2026, from $58.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $59.5 million in Q2 2026 to a low of $54.6 million in Q1 2022.
- A 5-year average of $56.6 million and a median of $56.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) fell 22.16% — and 2026, when it rose 2.69%.
- Tracing AGIO's Shares Outstanding (Entity) over 5 years: stood at $54.8 million in 2022, then rose by 1.57% to $55.7 million in 2023, then increased by 2.08% to $56.8 million in 2024, then grew by 2.05% to $58.0 million in 2025, then increased by 2.62% to $59.5 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $59.5 million (Q2 2026), $58.8 million (Q1 2026), and $58.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Agios Pharmaceuticals | 2.00 Bn | 1.38 Bn | 41.75 Mn | 59.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.49 Mn |
| Mar 31, 2026 | 58.78 Mn |
| Dec 31, 2025 | 57.97 Mn |
| Sep 30, 2025 | 58.14 Mn |
| Jun 30, 2025 | 57.93 Mn |
| Mar 31, 2025 | 57.46 Mn |
| Dec 31, 2024 | 56.81 Mn |
| Sep 30, 2024 | 56.94 Mn |
| Jun 30, 2024 | 56.80 Mn |
| Mar 31, 2024 | 56.38 Mn |
| Dec 31, 2023 | 55.65 Mn |
| Sep 30, 2023 | 55.80 Mn |
| Jun 30, 2023 | 55.60 Mn |
| Mar 31, 2023 | 55.27 Mn |
| Dec 31, 2022 | 54.79 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 54.80 Mn |
| Mar 31, 2022 | 54.56 Mn |
| Dec 31, 2021 | 60.45 Mn |
| Sep 30, 2021 | 57.05 Mn |